Leukemia Treatment

Concept

Development of a technology platform able to achieve complete remission of Chronic Lymphocytic Leukemia (CLL) with little or no side effects for the users.

Produtcs/Services

Technology platform for personalized treatments against CLL

Main achievements

Scientific and External Validation:

  • Finalised all pre-clinical research on DOT-Cells® for CLL – in vitro and in vivo studies;
  • Effective at eliminating cancer cells both in vitro and in vivo;
  • Strong evidence that the therapy is indeed capable of preventing tumour spread (metastasis) in humans;
  • No evidence of severe toxicity;
  • Validated by several leading immune-oncologists and haematologists;
  • The EMA confirmed potential significant benefit over all approved therapies.

More info at lymphact.com/